DrugPatentWatch Database Preview
Litigation Details for Adverio Pharma GmbH v. MSN Laboratories Private Limited (D. Del. 2018)
» See Plans and Pricing
Adverio Pharma GmbH v. MSN Laboratories Private Limited (D. Del. 2018)
| Docket | Start Trial | Date Filed | 2018-01-08 |
| Court | District Court, D. Delaware | Date Terminated | 2020-12-20 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Defendant | Referred To | |
| Parties | ALEMBIC GLOBAL HOLDING S/A | ||
| Patents | 6,743,798 | ||
| Attorneys | Adam K. Mortara | ||
| Firms | Shaw Keller LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Adverio Pharma GmbH v. MSN Laboratories Private Limited
The small molecule drug covered by the patent cited in this case is Start Trial .
Details for Adverio Pharma GmbH v. MSN Laboratories Private Limited (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-01-08 | 1 | action for patent infringement by Alembic of U.S. Patent No. 6,743,798 (“the ’798 Patent”), arising … 2004, the United States Patent and Trademark Office issued the ’798 Patent, entitled “Substituted Pyrazole…claimed in the ’798 Patent. 30. Adverio is the assignee of the ’798 Patent and holds title to…to the ’798 Patent. 31. Bayer AG is the exclusive licensee of the ’798 Patent in the United…798 Patent is listed in the Orange Book in association with Adempas®. The ’798 Patent claims | External link to document | |
| 2018-01-08 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,743,798 B1;. (sar) (Entered… 21 December 2020 1:18-cv-00073 835 Patent - Abbreviated New Drug Application(ANDA) Defendant | External link to document | |
| 2019-02-12 | 71 | have legal rights in U.S. Patent No. 6,743 ,798 (the "' 798 patent"), entitled "Substituted…product would not infringe the ' 798 patent and that the patent is invalid. (Id. 138; see also 21 U.S.C…pre-launch resolution of patent disputes between the parties with interests in the patents protecting a branded…quot;) prior to the expiration of the ' 798 patent. (Id. 11 1, 9, 10) Accordingly, Alembic has…Adverio Pharma is the assignee of the ' 798 patent and Bayer AG is the exclusive licensee in the United | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
